- $83.95bn
- $102.18bn
- £31.38bn
- 70
- 69
- 84
- 87
REG - GlaxoSmithKline PLC - Sotrovimab retains its activity vs Omicron variant
AnnouncementREG - Allianz Glbl Inv - Top 10 Holdings
AnnouncementREG - GlaxoSmithKline PLC - Sotrovimab retains its activity vs Omicron variant
AnnouncementREG-GlaxoSmithKline plc: Total Voting Rights
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - GSK publishes provisional 2022 dividend dates
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Nucala approved in Europe for more indications
AnnouncementREG - GlaxoSmithKline PLC - Block listing Interim Review
AnnouncementREG - GlaxoSmithKline PLC - Phase III IM administration data for sotrovimab
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - Allianz Glbl Inv - Top 10 Holdings
AnnouncementREG - GlaxoSmithKline PLC - GSK shares positive Phase III data for daprodustat
AnnouncementREG - GlaxoSmithKline PLC - Total Voting Rights
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - 3rd Quarter Results
AnnouncementREG - GlaxoSmithKline PLC - Directorate Change
Announcement